NZ Respiratory Research Review Issue 235

In this issue:

– Prebiologic disease trajectories: morbidity burden and response in severe asthma

– Patient-centred composite scores for assessing biologic response in severe asthma

– Inflammatory and clinical risk factors for asthma attacks

– Burden of asthma and atopic dermatitis 1990–2021, and out to 2050

– Phenotyping systemic corticosteroid responses in asthma attack management

– As-needed salbutamol budesonide in mild asthma

– Associations of ICS dose with adverse events

– Respiratory research in Māori and Pacific children in NZ

– Inflammation-induced loss of CFTR-expressing ionocytes in noneosinophilic asthma

– Type 1 immune responses related to viral infection affect corticosteroid response in asthma

– Lunsekimig for asthma

– Mepolizumab response trajectories in severe eosinophilic asthma

– Response/on-treatment remission with tezepelumab for severe, uncontrolled asthma

– Bronchial biopsy for predicting response to biologics in severe uncontrolled asthma